[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2149990T3 - Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes. - Google Patents

Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.

Info

Publication number
ES2149990T3
ES2149990T3 ES95920900T ES95920900T ES2149990T3 ES 2149990 T3 ES2149990 T3 ES 2149990T3 ES 95920900 T ES95920900 T ES 95920900T ES 95920900 T ES95920900 T ES 95920900T ES 2149990 T3 ES2149990 T3 ES 2149990T3
Authority
ES
Spain
Prior art keywords
isobutylphenyl
propionic acid
excipients
solid pharmaceutical
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920900T
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Alberto Pagano
Annibale Gazzaniga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Zambon SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Application granted granted Critical
Publication of ES2149990T3 publication Critical patent/ES2149990T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UN COMPUESTO FARMACEUTICO SOLIDO INDICADO PARA LA PREPARACION DE FORMULAS FARMACEUTICAS TALES COMO COMPRIMIDOS, SOBRES Y CAPSULAS, QUE CONTIENE COMO INGREDIENTE ACTIVO ACIDO PROPIONICO (S)-2-(4-ISOBUTILFENIL).
ES95920900T 1994-06-17 1995-05-26 Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes. Expired - Lifetime ES2149990T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941262A IT1270239B (it) 1994-06-17 1994-06-17 Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo

Publications (1)

Publication Number Publication Date
ES2149990T3 true ES2149990T3 (es) 2000-11-16

Family

ID=11369126

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920900T Expired - Lifetime ES2149990T3 (es) 1994-06-17 1995-05-26 Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.

Country Status (16)

Country Link
US (1) US5869102A (es)
EP (1) EP0758889B1 (es)
JP (1) JP3836507B2 (es)
AT (1) ATE195073T1 (es)
AU (1) AU696778B2 (es)
CZ (1) CZ285199B6 (es)
DE (1) DE69518237T2 (es)
DK (1) DK0758889T3 (es)
ES (1) ES2149990T3 (es)
GR (1) GR3034655T3 (es)
HU (1) HU219246B (es)
IT (1) IT1270239B (es)
NZ (1) NZ287445A (es)
PT (1) PT758889E (es)
RU (1) RU2168980C2 (es)
WO (1) WO1995035104A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
KR100700721B1 (ko) * 2000-09-08 2007-03-27 지상철 안정성 및 용출율이 향상된 ｓ(+)-이부프로펜의 정제
US6926938B2 (en) * 2001-01-10 2005-08-09 Suheung Capsule Co., Ltd. Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film
AU2002255190A1 (en) * 2001-04-10 2002-10-28 Fakhreddin Jamali Composition for enhanced absorption of nsaids
US6551615B1 (en) 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
WO2013154512A1 (en) * 2012-04-13 2013-10-17 Mahmut Bilgic Pharmaceutical formulations comprising dexibuprofen
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
GEP20002013B (en) * 1991-05-13 2000-04-10 Boots Co Plc Therapeutical Means
DK138592D0 (da) * 1992-11-17 1992-11-17 Nycomed Dak As Tabletter

Also Published As

Publication number Publication date
HU219246B (en) 2001-03-28
DE69518237T2 (de) 2001-02-22
IT1270239B (it) 1997-04-29
ITMI941262A0 (it) 1994-06-17
HUT76325A (en) 1997-08-28
US5869102A (en) 1999-02-09
DK0758889T3 (da) 2000-11-27
JPH10501537A (ja) 1998-02-10
PT758889E (pt) 2000-12-29
CZ366296A3 (en) 1997-11-12
JP3836507B2 (ja) 2006-10-25
AU2616795A (en) 1996-01-15
AU696778B2 (en) 1998-09-17
ATE195073T1 (de) 2000-08-15
EP0758889A1 (en) 1997-02-26
NZ287445A (en) 1998-05-27
HU9603463D0 (en) 1997-02-28
EP0758889B1 (en) 2000-08-02
WO1995035104A1 (en) 1995-12-28
CZ285199B6 (cs) 1999-06-16
RU2168980C2 (ru) 2001-06-20
ITMI941262A1 (it) 1995-12-17
DE69518237D1 (de) 2000-09-07
GR3034655T3 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
ES2149990T3 (es) Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.
EP0264187B1 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
HRP20000142B1 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
SI9620036B (sl) Derivat aminotetralina za terapijo kardiovaskularnih bolezni
CA2191855A1 (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
IT1238205B (it) Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche.
ECSP941154A (es) Procedimiento para preparar una composicion farmaceutica a base de ciclosporina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758889

Country of ref document: ES